Cytosorbents Corp

-0.24 (-4.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)208.03M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.77 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$5.40
50-Day MA$6.62
200-Day MA$8.04
See more pivots

Cytosorbents Corp Stock, NASDAQ:CTSO

7 Deer Park Drive, Suite K, Monmouth Junction, New Jersey 08852
United States of America
Phone: +1.732.329.8885
Number of Employees: 195


CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.